These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18459053)

  • 1. Determination of reference ultrasound parameters for model and hydrofluoroalkane propellants using high-resolution ultrasonic spectroscopy.
    Hoe S; Young PM; Rogueda P; Traini D
    AAPS PharmSciTech; 2008; 9(2):605-11. PubMed ID: 18459053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel pMDI formulations for pulmonary delivery of proteins.
    Li HY; Seville PC
    Int J Pharm; 2010 Jan; 385(1-2):73-8. PubMed ID: 19854252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-pressure aerosol suspensions--a novel laser diffraction particle sizing system for hydrofluoroalkane pressurised metered dose inhalers.
    Jones SA; Martin GP; Brown MB
    Int J Pharm; 2005 Sep; 302(1-2):154-65. PubMed ID: 16102928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing an in vitro understanding of patient experience with hydrofluoroalkane-metered dose inhalers.
    Doub WH; Shah V; Limb S; Guo C; Liu X; Ngo D
    J Pharm Sci; 2014 Nov; 103(11):3648-3656. PubMed ID: 25228114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of Aerosol Hydrofluoroalkane HFA-134a Elimination in the Exhaled Human Breath Following Inhaled Corticosteroids Administration.
    Shin HW; Barletta B; Yoonessi L; Meinardi S; Leu SY; Radom-Aizik S; Randhawa I; Nussbaum E; Blake DR; Cooper DM
    Clin Transl Sci; 2015 Oct; 8(5):445-50. PubMed ID: 26155923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of metered dose inhaler spray velocities using phase Doppler anemometry (PDA).
    Liu X; Doub WH; Guo C
    Int J Pharm; 2012 Feb; 423(2):235-9. PubMed ID: 22183132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a.
    Tarara TE; Hartman MS; Gill H; Kennedy AA; Weers JG
    Pharm Res; 2004 Sep; 21(9):1607-14. PubMed ID: 15497686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deposition and pharmacokinetics of flunisolide delivered from pressurized inhalers containing non-CFC and CFC propellants.
    Richards J; Hirst P; Pitcairn G; Mahashabde S; Abramowitz W; Nolting A; Newman SP
    J Aerosol Med; 2001; 14(2):197-208. PubMed ID: 11681651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isothermal calorimetry: a predictive tool to model drug-propellant interactions in pressurized metered dose systems.
    Ooi J; Gaisford S; Boyd BJ; Young PM; Traini D
    Int J Pharm; 2014 Jan; 461(1-2):301-9. PubMed ID: 24325938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
    Bousquet J; Huchon G; Leclerc V; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():6-12. PubMed ID: 15915007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation of the solubility of various compounds in the hydrofluoroalkane propellants and possible model liquid propellants.
    Dickinson PA; Seville PC; McHale H; Perkins NC; Taylor G
    J Aerosol Med; 2000; 13(3):179-86. PubMed ID: 11066021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CFC to HFA transition and its impact on pulmonary drug development.
    Leach CL
    Respir Care; 2005 Sep; 50(9):1201-8. PubMed ID: 16122403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin nanoparticles: stability and aerosolization from pressurized metered dose inhalers.
    Nyambura BK; Kellaway IW; Taylor KM
    Int J Pharm; 2009 Jun; 375(1-2):114-22. PubMed ID: 19481697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plume temperature emitted from metered dose inhalers.
    Brambilla G; Church T; Lewis D; Meakin B
    Int J Pharm; 2011 Feb; 405(1-2):9-15. PubMed ID: 21129465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse aqueous microemulsions in hydrofluoroalkane propellants and their aerosol characteristics.
    Selvam P; Bharatwaj B; Porcar L; da Rocha SR
    Int J Pharm; 2012 Jan; 422(1-2):428-35. PubMed ID: 22044539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of Methods for Evaluating Particle Stability in Suspension Based Pressurized Metered Dose Inhalers.
    D'Sa D; Chan HK
    Curr Pharm Des; 2015; 21(27):3955-65. PubMed ID: 26290200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of metered dose inhaler (MDI) formulations of ciclosporin.
    Marijani R; Shaik MS; Chatterjee A; Singh M
    J Pharm Pharmacol; 2007 Jan; 59(1):15-21. PubMed ID: 17227616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers.
    Smyth HD; Hickey AJ
    AAPS PharmSciTech; 2003; 4(3):E38. PubMed ID: 14621970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of polyvinyl alcohol on the in vitro stability and delivery of spray-dried protein particles from surfactant-free HFA 134a-based pressurised metered dose inhalers.
    Liao YH; Brown MB; Jones SA; Nazir T; Martin GP
    Int J Pharm; 2005 Nov; 304(1-2):29-39. PubMed ID: 16181753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology.
    Kleinstreuer C; Shi H; Zhang Z
    J Aerosol Med; 2007; 20(3):294-309. PubMed ID: 17894536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.